Device type · JFY
Enzymatic Method, Creatinine
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JFY
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
9
510(k), De Novo and PMA
Adverse event reports
77
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Enzymatic Method, Creatinine
- Product code
- JFY
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JFY
Latest FDA decisions
The 8 newest of 9 since 2015.
- QSCHECK UISACR510(k)
K252619 · Decided Feb 20, 2026 · 185 days after receipt
Device type: Enzymatic Method, Creatinine (JFY) · Laboratory Medicine & Pathology
Siemens Healthcare Diagnostics, Inc.
K212223 · Decided Nov 24, 2021 · 131 days after receipt
Device type: Enzymatic Method, Creatinine (JFY) · Laboratory Medicine & Pathology
K193649 · Decided May 10, 2021 · 497 days after receipt
Device type: Enzymatic Method, Creatinine (JFY) · Laboratory Medicine & Pathology
6 more FDA decisions with a free account
Reports received
77
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
77
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 2 | 0 | 0 | 0 |
| Feb 24 | 2 | 0 | 0 | 0 |
| Mar 24 | 4 | 0 | 0 | 0 |
| Apr 24 | 3 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 1 | 0 | 0 | 0 |
| Jul 24 | 4 | 0 | 0 | 0 |
| Aug 24 | 6 | 0 | 0 | 0 |
| Sep 24 | 4 | 0 | 0 | 0 |
| Oct 24 | 2 | 0 | 0 | 0 |
| Nov 24 | 3 | 0 | 0 | 0 |
| Dec 24 | 2 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 2 | 0 | 0 | 0 |
| Mar 25 | 19 | 0 | 0 | 0 |
| Apr 25 | 7 | 0 | 0 | 0 |
| May 25 | 1 | 0 | 0 | 0 |
| Jun 25 | 3 | 0 | 0 | 0 |
| Jul 25 | 2 | 0 | 0 | 0 |
| Aug 25 | 3 | 0 | 0 | 0 |
| Sep 25 | 4 | 0 | 0 | 0 |
| Oct 25 | 5 | 0 | 0 | 0 |
| Nov 25 | 6 | 0 | 0 | 0 |
| Dec 25 | 7 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 1 | 0 | 0 | 0 |
| Mar 26 | 11 | 0 | 0 | 0 |
| Apr 26 | 10 | 0 | 0 | 0 |
| May 26 | 3 | 0 | 0 | 0 |
| Jun 26 | 3 | 0 | 0 | 0 |
| Jul 26 | 3 | 0 | 0 | 0 |
| Aug 26 | 8 | 0 | 0 | 0 |
| Sep 26 | 5 | 0 | 0 | 0 |
| Oct 26 | 20 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
2 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- High Test Results50
- Non Reproducible Results19
- Low Test Results8
5 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions75
- Insufficient Information2
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2873-2020 · Started Jul 13, 2020
Reason given: Etrombopag Interference for VITROS Chemistry Products: TBIL Slides, VITROS BuBc Slides and VITROS XT TBIL-ALKP Slides
Cause as FDA categorized it: Other
Siemens Healthcare Diagnostics, Inc.
Z-2282-2020 · Started May 4, 2020 · Posted by FDA Jun 5, 2020
Reason given: The presence of N-acetyl-p-benzoquinone imine (NAPQI), a metabolite of acetaminophen, may cause interference in certain chemistry assays when testing patient samples.
Cause as FDA categorized it: Device Design
Siemens Healthcare Diagnostics, Inc.
Z-2283-2020 · Started May 4, 2020 · Posted by FDA Jun 5, 2020
Reason given: The presence of N-acetyl-p-benzoquinone imine (NAPQI), a metabolite of acetaminophen, may cause interference in certain chemistry assays when testing patient samples.
Cause as FDA categorized it: Device Design
26 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.